Gene · 4174
Papers2,000
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,000
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of RUVBL2 as a novel biomarker to predict the prognosis and drug sensitivity in multiple myeloma based on ferroptosis genes. | Hematology | 2025 | 39985176 | PubTator, text mining | PubMed |
| TFAP4 Regulation of MCM5 Activates the PI3K/AKT Pathway to Promote Invasion and Metastasis of Gastric Cancer. | Dig Dis Sci | 2025 | 39971831 | PubTator, text mining | PubMed |
| Refinement and curation of homologous groups facilitated by structure prediction. | Protein Sci | 2025 | 39968854 | PubTator, text mining | PubMed |
| Unidirectional MCM translocation away from ORC drives origin licensing. | Nat Commun | 2025 | 39824870 | PubTator, text mining | PubMed |
| TanGIBLE: A selective probe for evaluating hydrophobicity-exposed defective proteins in live cells. | J Cell Biol | 2025 | 39812643 | PubTator, text mining | PubMed |
| Functional Analysis and Experimental Validation of the Prognostic and Immune Effects of the Oncogenic Protein CDC45 in Breast Cancer. | Breast Cancer (Dove Med Press) | 2025 | 39811603 | PubTator, text mining | PubMed |
| MCM2-7 ring closure involves the Mcm5 C-terminus and triggers Mcm4 ATP hydrolysis. | Nat Commun | 2025 | 39747125 | PubTator, text mining | PubMed |
| Statistical modeling of single-cell epitranscriptomics enabled trajectory and regulatory inference of RNA methylation. | Cell Genom | 2025 | 39642887 | PubTator, text mining | PubMed |
| Recurrent hepatocellular carcinoma is associated with the enrichment of MYC targets gene sets, elevated high confidence deleterious mutations and alternative splicing of DDB2 and BRCA1 transcripts. | Adv Med Sci | 2025 | 39486583 | PubTator, text mining | PubMed |
| Investigating the Mechanisms of Anti-tumoral Effect of Combination Therapy of Calcitriol and Sodium Pentaborate Pentahydrate on HepG2 Hepatocellular Carcinoma Cells. | Biol Trace Elem Res | 2025 | 39441231 | PubTator, text mining | PubMed |
| Chromatin licensing and DNA replication factor 1 as a potential prognostic and diagnostic biomarker for gastric cancer. | Sci Rep | 2024 | 39730687 | PubTator, text mining | PubMed |
| Interspecies transcriptome profiles of human T cell activation and liver inflammation in a xenogeneic graft-versus-host disease model. | Heliyon | 2024 | 39687194 | PubTator, text mining | PubMed |
| Retraction: miR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma. | Biosci Rep | 2024 | 39501752 | PubTator, text mining | PubMed |
| The shared mechanism and potential diagnostic markers for premature ovarian failure and dry eye disease. | Sci Rep | 2024 | 39003404 | PubTator, text mining | PubMed |
| MCM5 is a Novel Therapeutic Target for Glioblastoma. | Onco Targets Ther | 2024 | 38765057 | PubTator, text mining | PubMed |
| MEG3 shuttled by exosomes released from human bone marrow mesenchymal stem cells promotes TP53 stability to regulate MCM5 transcription in keloid fibroblasts. | J Gene Med | 2024 | 38686583 | PubTator, text mining | PubMed |
| A Decade of Discovery-Eukaryotic Replisome Disassembly at Replication Termination. | Biology (Basel) | 2024 | 38666845 | PubTator, text mining | PubMed |
| Identification of genes related to ribosomal proteins in colorectal cancer: exploring their potential as biomarkers, prognostic indicators, and therapeutic targets. | Mol Biol Rep | 2024 | 38664314 | PubTator, text mining | PubMed |
| Surveying biomedical relation extraction: a critical examination of current datasets and the proposal of a new resource. | Brief Bioinform | 2024 | 38609331 | PubTator, text mining | PubMed |
| Bioinformatics identification of characteristic genes of cervical cancer via an artificial neural network. | Chin Clin Oncol | 2024 | 38453655 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4174/papers?page=3